Inside story of Kodak's surge on $765m White House loan to pivot into drugs

Mostly forgotten photography icon Eastman Kodak jumped into the headlines this month after the Trump White House picked it out for special treatment in a plan to move production of chemicals that go into cornavirus drugs back to the US. The now tiny US company was incentivised through a $765m government loan - news of which sent its share price from $2 to over $60 before easing back to close the session at $33 and ease back further to its current $10, still five times the pre-loan announcement. Here's the inside story from our partners at the Wall Street Journal. Learn more about your ad choices. Visit megaphone.fm/adchoices